Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$307.76 USD

307.76
1,044,929

-1.08 (-0.35%)

Updated May 3, 2024 04:00 PM ET

After-Market: $307.76 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 9% (22 out of 252)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?

Here is how Addus HomeCare (ADUS) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics

Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.

Here's Why You Should Retain STERIS (STE) Stock for Now

STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.

Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View

Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.

Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs

Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.

Teladoc Health (TDOC) Q1 Loss Widens on Decline in Visits

Teladoc Health's (TDOC) Q1 results suffer from weak contributions from the BetterHelp unit. Management expects U.S. Integrated Care Members of 92-94 million for 2024, up from the prior mentioned 90-92 million.

Is HCA Healthcare (HCA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know

Zacks.com users have recently been watching HCA (HCA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Here's Why You Should Buy Bruker (BRKR) Stock Right Now

Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.

Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise

Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.

HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions

HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.

HCA (HCA) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HCA Healthcare (HCA) Q1 Earnings and Revenues Beat Estimates

HCA (HCA) delivered earnings and revenue surprises of 6.99% and 2.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand

ResMed's (RMD) fiscal 2024 third-quarter performance reflects another strong period of execution across the entire business, resulting in impressive top and bottom-line growth.

The Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare

Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare are part of the Zacks top Analyst Blog.

Kaibalya Pravo Dey headshot

Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat

Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.

Why Earnings Season Could Be Great for HCA Healthcare (HCA)

HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks.com featured highlights include Hubbel, Caterpillar, The Timken Co. and HCA Healthcare

Hubbel, Caterpillar, The Timken Co. and HCA Healthcare are part of the Zacks Screen of the Week article.

Community Health Systems (CYH) Reports Q1 Loss, Tops Revenue Estimates

Community Health Systems (CYH) delivered earnings and revenue surprises of 26.32% and 1.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Scoop up These 4 GARP Stocks to Receive Handsome Returns

The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HUBB, CAT, TKR and HCA are some stocks that hold promise.

Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect

Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.

Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?

Teladoc's (TDOC) first-quarter results are expected to have benefited from higher visits. However, high costs might have partially offset the positives.